American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Donate
Your AHNS Member Panel

Head and Neck Surgeon

Jonathan Giurintano – Washington, District of Columbia

Published on by Jonathan Giurintano

Practice Contact Information

Georgetown University
3800 Reservoir Road Northwest
Gorman Building 1st Floor
Washington
District of Columbia
20007
United States

Phone:
Email: [email protected]
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

A native of Jackson, MS, I currently serve as Assistant Professor of Otolaryngology – Head and Neck Surgery at MedStar Georgetown University Hospital in Washington, DC. I completed medical school at the University of Mississippi School of Medicine, Otolaryngology – Head and Neck Surgery residency at the University of Tennessee Health Science Center in Memphis, TN, and fellowship training in Head & Neck Oncologic Surgery, Anterior Skull Base Surgery, and Microvascular Reconstruction at UCSF Medical Center in San Francisco, CA. I am a diplomate of the American Board of Otolaryngology – Head and Neck Surgery. I am active in all areas of head and neck surgery, including aerodigestive tract malignancies, endocrine surgery, paranasal sinus tumors, salivary gland surgery, and microvascular reconstruction. I live in Washington, DC, with my wife Taylor, a general dentist, our dachshund Oscar, and our cat Juno.

Clinical Trials

Bibliography

Rodrigo Arrangoiz – Mexico City, Mexico City

Published on by Rodrigo Arrangoiz

Practice Contact Information

Sociedad Quirúrgica S.C. at the American British Cowdray Medical Center
Av. Carlos Graef Fernandez # 154 – 515
Colonia Tlaxala, Delegación Cuajimalpa
Mexico City
Mexico City
05300
Mexico

Phone: 5255166647200
Email:
Web Site: http://www.sociedadquirurgica.com

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon

Biography/Statement

  • I went to medical school at the Anahuac University in Mexico City, which is one of the most prestigious medical schools in Mexico:
    • I graduated Suma Cum Laude from this medical school and was the president of the student medical council.
  • I trained in general surgery at Michigan State University where I was named chief resident during my fifth year of residency which was a great honor.
  • My complex surgical oncology fellowship which included a head and neck training was performed at the Fox Chase Cancer Center in Philadelphia, Pennsylvania.
  • At the same time, I undertook a Masters in Science (Clinical Research for Health Care Professionals) at Drexel University in Philadelphia, Pennsylvania.
  • I also performed a two-year global online fellowship in Head and Neck Surgery and Oncology with the International Federations of Head and Neck Societies / Memorial Sloan Kettering Cancer Center.
    • I encountered patients with very complex problems, and the greatest lesson I learned was there are always treatment options, utilizing all different types of techniques including radiation, chemotherapy and surgery.
      • This comprehensive training has provided me with an extensive understanding of the multidisciplinary approach to treating patients with cancer.
  • I have developed a particularly strong interest in the surgical and multimodal treatment of patients with breast cancer, head and neck cancer (including thyroid and parathyroid cancer), and endocrine diseases (benign and malignant thyroid and parathyroid diseases), using traditional surgery, regional therapies, and minimally invasive techniques.
    • I am an expert in the treatment of thyroid cancer including; active surveillance for early, small papillary thyroid cancers, minimally invasive thyroid surgery, selective and comprehensive neck dissections.
    • For the management of parathyroid disease, I offer a minimally invasive radio-guided technique called MIRP (minimally invasive radio-guided parathyroidectomy) through a 2 cm incision which will allow the patient to have a great cosmetic result and quick return to normal life after the operation.
  • I hold my patients as my number one priority. I will spend as much time as necessary educating, answering questions and providing guidance for each individual patient to help them throughout each stage of their management. I believe in honest discussions, where both the patients and family’s goals and expectations are openly communicated. We will work together as a team to put together an evidence based personalized treatment plan. My personal goal is to treat and care for every patient with the same compassion and honesty as if they were a friend or family member.

Clinical Trials

Bibliography

Frederic Ogren – Omaha, Nebraska

Published on by Frederic Ogren

Practice Contact Information

CHI Health/Creighton University
17030 Lakeside Hills Plaza
Suite 204
Omaha
Nebraska
68130
United States

Phone: 402 758 5600
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon

Biography/Statement

I am an Otolaryngologist/Head & Neck Surgeon with special interests in Voice and Swallowing Disorders and Thyroid/Parathyroid Surgery.

Clinical Trials

Bibliography

Alex Senchenkov, MD, FACS – Bradenton, Florida

Published on by Alex Senchenkov

Practice Contact Information

Alex Senchenkov, MD, FACS
6310 Health Park Way
Suite 110
Bradenton
Florida
34202
United States

Phone: 5073982753
Email: [email protected]
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Alex Senchenkov, MD, completed his medical education with honors in the Ukrainian State Medical University, Kiev, Ukraine in 1993. He subsequently worked at the Kiev Research Institute of Oncology as a staff surgical oncologist prior to immigrating. In the US, Dr Senchenkov worked at John Wayne Cancer Institute, Santa Monica, CA and then completed residency training in Surgery at The Medical College of Ohio, Toledo, OH and Plastic Surgery at Mayo Clinic, Rochester, MN. He subsequently completed fellowships in Microsurgery at the University of Pittsburgh and Head & Neck Surgical Oncology at the University of Cincinnati. Dr. Senchenkov holds active board certifications by the American Board of Surgery and the American Board of Plastic Surgery.

The practice is focused on delivering high-quality, personalized care to the patients with head and neck tumors, thyroid/parathyroid problems, craniofacial deformities, and oncologic microsurgical reconstructive needs. All insurance plans including Medicaids are accepted or negotiated with insurance companies for rates. We serve patients who travel from out-of-state for care.

Clinical Trials

Bibliography

Miriam Lango – Houston, Texas

Published on by Miriam Lango

Practice Contact Information

MD Anderson Cancer Center
1515 Holcombe Boulevard

Houston
Texas
77030
United States

Phone:
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Surgeon

Biography/Statement

I was a faculty member at the Fox Chase Cancer Center for 15 years prior to joining MD Anderson Cancer Center in 2019. As a faculty member at comprehensive cancer centers, I believe that multidisciplinary head and neck and endocrine cancer care will yield the best outcomes for patients. My research endeavors have involved functional outcomes and quality of life in head and neck cancer, and health care delivery issues and tumor markers. These endeavors are more fully described below. My research and clinical experience have laid the groundwork for quality of life studies in other tumor types.

Clinical Trials

Bibliography

 

  1. Ebersole B, Lango M, Ridge J, et al. Dysphagia Screening for Pneumonia Prevention in a Cancer Hospital: Results of a Quality/Safety Initiative. Otolaryngol Head Neck Surg. 2019: Dec 3 ePub.
  2. Roldan CS, Chen JJ, Fareed MM, Hameed MY, Churilla TM, Lango MN et al. Impact of primary tumor-specific growth rate on treatment failure for nonropharyngeal head and neck cancers. 2019 ePub.
  3. Lee CT, Lehrer EJ, Aphale A, Lango M, Galloway TJ, Zaorsky NG. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients. 2019 Oct 15;125(20):3582-3594.
  4. Dong Y, Ridge JA, Ebersole B, Li T, Lango MN et al. Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer. Oral oncology. 2019; 95:59-64.
  5. Tang, J and Lango M. Diverging incidence trends for larynx and tonsil cancer in low socioeconomic regions of the US. Oral oncology. 2019 Apr; 91:65-68.
  6. Ebersole B, Soni RS, Moran K, Lango M, Devarajan K, Jamal N. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence. Journal of voice : official journal of the Voice Foundation 2018; 32:325-331.
  7. Moten AS, Lango MN, Goel N, Goldberg AJ. Regional diagnostic rates, treatments, and outcomes among patients with invasive ductal carcinoma. The Journal of surgical research 2018; 229:114-121.
  8. Zuniga SA, Lango MN. Effect of rural and urban geography on larynx cancer incidence and survival.Laryngoscope. 2018 Aug;128(8):1874-1880.
  9. Dong Y, Ridge JA, Li T, Lango M, et al. Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer. Oral oncology 2017; 71:122-128.
  10. Ebersole B, Soni RS, Moran K, Lango M et al. The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence. Journal of voice : official journal of the Voice Foundation2018 May;32(3):325-331.
  11. Wang LS, Handorf EA, Ridge JA, Burtness B, Lango M et al. Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification. Ear, nose, & throat journal 2017; 96:E12-e18.
  12. Liu JC, Sopka DS, Mehra R, Lango M et al. Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence. World J Otorhinolaryngol Head Neck Surg 2016; 2:193-197.
  13. Smith A, Handorf E, Arjmand E, Lango MN. Predictors of regional Medicare expenditures for otolaryngology physician services. 2017;127(6):1312-1317.
  14. Beck TN, Georgopoulos R, Shagisultanova EI, Sarcu D, Handorf EA, Dubyk C, Lango MN et al. EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer. Mol Cancer Ther. 2016 Oct: 15 (10): 2486-2497.
  15. Lango MN, Handorf E, Arjmand E. The geographic distribution of the otolaryngology workforce in the United States. Laryngoscope 2016 Oct 24.
  16. Koshkareva Y, Liu JC, Lango M, Galloway T, Gaughan JP, Ridge JA. Cervical metastases in squamous cell carcinoma of the hard palate and maxillary alveolus. Ear Nose Throat J. 2016 Oct-Nov;95(10-11):E6-E11.
  17. Beck TN, Georgopoulos R, Shagisultanova EI, Sarcu D, Handorf EA, Dubyk C, Lango MN, et al. EGFR and RB1 as dual markers in HPV-negative head and neck cancer. Mol Cancer Ther. 2016 Oct;15(10):2486-2497.
  18. Azadarmaki R, Then MT, Walia R, Lango MN. Cavernous hemangioma of the submandibular gland with parapharyngeal extension in an adult: Case report. Ear Nose Throat J. 2016 Feb;95(2):E11-3.
  19. Lango MN, Galloway T, Mehra R, Ebersole B, Liu J, Moran K, Ridge JA. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation. Head Neck. 2016 Apr;38 Suppl 1:E1318-24.
  20. Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R. Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck. Oncotarget 2015 Aug 7;6(22):18863-74.
  21. Aaron H, Azadarmaki R, Lango MN. Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine: Case Report and Literature Review. Am J Ther. 2016 Mar-Apr;23(2):e621-3.
  22. Patel SA, Abdollahi H, Ridge JA, Chang EI, Lango MN, Topham NS. Asymptomatic Deep Peroneal Vein Thrombosis During Free Fibula Flap Harvest: A Review of the Literature, Strategies for Preoperative Assessment, and an Algorithm for Reconstruction. Ann Plast Surg. 2016 Apr;76(4):468-71.
  23. Lango MN, Galloway T, Mehra R, Ebersole B, Liu J, Moran K, Ridge JA. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation. Head Neck. 2016 Apr;38 Suppl 1:E1318-24.
  24. Cracchiolo J, Ridge JA, Egleston B, Lango M. Practice arrangement and Medicare physician payment in otolaryngology. Otolaryngol Head Neck Surg. 2015 Jun;152(6):979-87.
  25. Arrangoiz R, Galloway TJ, Papavasiliou P, Ridge JA, Lango MN. Metastatic cervical carcinoma from an unknown primary: literature review. Ear Nose Throat J. 2014 Apr-May;93(4-5):E1-10. Review.
  26. Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. 2014 Mar 15;120(6):840-7.
  27. Doss M, Kolb HC, Walsh JC, Mocharla V, Fan H, Chaudhary A, Zhu Z, Alpaugh RK, Lango MN, Yu JQ. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers. J Nucl Med. 2013 Dec;54(12):2087-92.
  28. Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang D, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head Neck. 2014 Dec;36(12):1677-84.
  29. Mehra R, Zhu F, Yang DH, Cai KQ, Weaver J, Singh MK, Nikonova AS, Golemis EA, Flieder DB, Cooper HS, Lango M, Ridge JA, Burtness B. Quantification of excision  repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers. Clin Cancer Res. 2013 Dec 1;19(23):6633-43.
  30. Sopka DM, Li T, Lango MN, Mehra R, Liu JC, Burtness B, Flieder DB, Ridge JA, Galloway TJ. Dysplasia at the margin? Investigating the case for subsequent therapy in ‘low-risk’ squamous cell carcinoma of the oral tongue. Oral Oncol. 2013 Nov;49(11):1083-7.
  31. Fang CY, Egleston BL, Ridge JA, Lango MN, Bovbjerg DH, Studts JL, Burtness BA, Einarson MB, Klein-Szanto AJ. Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer. Head Neck. 2014 Aug;36(8):1113-9.
  32. Lango M, Flieder D, Arrangoiz R, Veloski C, Yu JQ, Li T, Burtness B, Mehra R, Galloway T, Ridge JA. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. 2013 Sep;23(9):1099-105.
  33. Fang CY, Longacre ML, Manne SL, Ridge JA, Lango MN, Burtness BA. Informational Needs of Head and Neck Cancer Patients. Health Technol (Berl). 2012 Apr 1;2(1):57-62.
  34. Galloway TJ, Lango MN, Burtness B, Mehra R, Ruth K, Ridge JA. Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns. Head 2013 Feb;35(2):160-4.
  35. Andrews G, Lango M, Cohen R, Feigenberg S, Burtness B, Mehra R, Ahmed S, Nicolaou N, Gaughan J, Ridge JA. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck. 2011 Oct;33(10):1433-40.
  36. Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol. 2010 Dec;33(6):599-603.
  37. Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):65-70.
  38. Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen C. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1020-5.
  39. Lango MN, Egleston B, Ende K, Feigenberg S, D’Ambrosio DJ, Cohen RB, Ahmad S, Nicolaou N, Ridge JA. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010 Mar;32(3):341-7.
  40. Lango MN, Andrews GA, Ahmad S, Feigenberg S, Tuluc M, Gaughan J, Ridge JA. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck. 2009 Mar;31(3):328-37.
  41. Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res. 2006 Sep 1;12(17):5064-73.
  42. Lango M, Wentzel AL, Song JI, Xi S, Johnson DE, Lamph WW, Miller L, Grandis JR. Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells. Clin Cancer Res. 2003 Sep 15;9(11):4205-13.
  43. Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM, Grandis JR. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 2002 Mar 6;94(5):375-83.
  44. Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines. Cancer Res. 2001 Aug 1;61(15):5919-25.
  45. Shah SI, Yip L, Greenberg B, Califano JA, Chow J, Eisenberger CF, Lee DJ, Sewell DA, Reed AL, Lango M, Jen J, Koch WM, Sidransky D. Two distinct regions of loss on chromosome arm 4q in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2000 Sep;126(9):1073-6.
  46. Endo S, Zeng Q, Burke NA, He Y, Melhem MF, Watkins SF, Lango MN, Drenning SD, Huang L, Rubin Grandis J. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo. Gene Ther.2000 Nov;7(22):1906-14.
  47. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. 1999 Oct;109(10):1544-51.
  48. Donohue TJ, Dworkin LD, Ma J, Lango MN, Catanese VM. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I. J Investig Med. 1997 Dec;45(9):584-91.
  49. Linn JF, Lango M, Halachmi S, Schoenberg MP, Sidransky D. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Int J Cancer. 1997 Dec 19;74(6):625-9.
  50. Lee DJ, Koch WM, Yoo G, Lango M, Reed A, Califano J, Brennan JA, Westra WH, Zahurak M, Sidransky D. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res.1997 Apr;3(4):501-5.
  51. Califano JA, Johns MM 3rd, Westra WH, Lango MN, Eisele D, Saji M, Zeiger MA, Udelsman R, Koch WM, Sidransky D. An allelotype of papillary thyroid cancer. Int J Cancer. 1996 Dec 20;69(6):442-4.
  52. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR, Catanese VM. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. 1994 Feb;89(2):799-809.
  53. Catanese VM, Sciavolino PJ, Lango MN. Discordant, organ-specific regulation of insulin-like growth factor-I messenger ribonucleic acid in insulin-deficient diabetes in rats. 1993 Feb;132(2):496-503.